EP2763540A4 - Compositions et procédés d'évaluation et de traitement de maladies et de troubles inflammatoires - Google Patents
Compositions et procédés d'évaluation et de traitement de maladies et de troubles inflammatoiresInfo
- Publication number
- EP2763540A4 EP2763540A4 EP12829361.0A EP12829361A EP2763540A4 EP 2763540 A4 EP2763540 A4 EP 2763540A4 EP 12829361 A EP12829361 A EP 12829361A EP 2763540 A4 EP2763540 A4 EP 2763540A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- diseases
- evaluation
- compositions
- treatment
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 238000011156 evaluation Methods 0.000 title 1
- 208000027866 inflammatory disease Diseases 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161532902P | 2011-09-09 | 2011-09-09 | |
| US201261584988P | 2012-01-10 | 2012-01-10 | |
| PCT/US2012/033753 WO2013036290A1 (fr) | 2011-09-09 | 2012-04-16 | Compositions et procédés d'évaluation et de traitement de maladies et de troubles inflammatoires |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP2763540A1 EP2763540A1 (fr) | 2014-08-13 |
| EP2763540A4 true EP2763540A4 (fr) | 2015-04-22 |
Family
ID=47832488
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP12829361.0A Withdrawn EP2763540A4 (fr) | 2011-09-09 | 2012-04-16 | Compositions et procédés d'évaluation et de traitement de maladies et de troubles inflammatoires |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP2763540A4 (fr) |
| WO (1) | WO2013036290A1 (fr) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011503104A (ja) | 2007-11-09 | 2011-01-27 | カリフォルニア インスティテュート オブ テクノロジー | 免疫調節化合物ならびに関連組成物および方法 |
| WO2011127302A2 (fr) | 2010-04-07 | 2011-10-13 | Yue Shen | Véhicule destiné à distribuer un composé à une muqueuse et compositions, procédés et systèmes apparentés |
| WO2013009945A1 (fr) | 2011-07-12 | 2013-01-17 | The Brigham And Women's Hospital, Inc. | Compositions de psa contenant des lipides, procédés d'isolement et procédés pour les utiliser |
| EP2909334B1 (fr) | 2012-10-17 | 2020-06-24 | Enterome | Signatures génétiques de troubles métaboliques liés au foie et de la maladie de crohn |
| EP2969012A4 (fr) | 2013-03-12 | 2016-09-14 | Univ Yale | Compositions et méthodes pour identifier des microbes liés à des anticorps sécrétoires |
| EP2994161B1 (fr) | 2013-05-10 | 2020-10-28 | California Institute of Technology | Prévention et traitement probiotiques du cancer du côlon |
| WO2015066625A1 (fr) * | 2013-11-01 | 2015-05-07 | Washington University | Méthodes pour établir et restaurer la fonction normale du microbiote intestinal chez un sujet en ayant besoin |
| FI127671B (en) * | 2014-05-28 | 2018-11-30 | Filip Scheperjans | Method for diagnostics of Parkinson’s disease |
| EP3188741A4 (fr) | 2014-08-28 | 2018-03-28 | Yale University | Compositions et méthodes pour le traitement d'une maladie ou d'un trouble inflammatoire |
| US9968616B2 (en) | 2014-10-25 | 2018-05-15 | The Chinese University Of Hong Kong | Discovery of FDA-approved drugs as inhibitors of fatty acid binding protein 4 using molecular docking screening |
| EP3679798B1 (fr) * | 2015-02-03 | 2021-11-17 | Mayo Foundation for Medical Education and Research | Procédés et matériaux permettant d'évaluer et de traiter l'arthrite |
| WO2016201342A1 (fr) | 2015-06-10 | 2016-12-15 | California Institute Of Technology | Traitement du sepsis, compositions, méthodes et systèmes associés |
| CA2997211A1 (fr) | 2015-08-19 | 2017-02-23 | President And Fellows Of Harvard College | Compositions de psa lipides et procedes associes |
| CA3030974A1 (fr) | 2016-07-15 | 2018-01-18 | President And Fellows Of Harvard College | Compositions de glycolipide et procedes d'utilisation |
| WO2021262601A1 (fr) * | 2020-06-22 | 2021-12-30 | Regeneron Pharmaceuticals, Inc. | Traitement de l'obésité au moyen d'inhibiteurs du récepteur 75 couplé à la protéine g (gpr75) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004045525A2 (fr) * | 2002-11-15 | 2004-06-03 | Morehouse School Of Medicine | Anticorps anti-chimiokines et anticorps anti-recepteurs associes et utilisations de ces anticorps pour inhiber des inflammations |
| WO2005016226A2 (fr) * | 2003-08-14 | 2005-02-24 | Hadasit Medical Research Services & Development Ltd. | Compositions pharmaceutiques comprenant des antagonistes de ccr5 |
| WO2011043654A1 (fr) * | 2009-10-05 | 2011-04-14 | Aak Patent B.V. | Procédé de diagnostic du syndrome du côlon irritable |
| WO2011082218A1 (fr) * | 2009-12-31 | 2011-07-07 | Ira Milton Trachtman | Compositions et procédés pour traitement et prophylaxie d'une maladie intestinale inflammatoire |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4256108A (en) | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
| US4160452A (en) | 1977-04-07 | 1979-07-10 | Alza Corporation | Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina |
| US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
| US5023243A (en) | 1981-10-23 | 1991-06-11 | Molecular Biosystems, Inc. | Oligonucleotide therapeutic agent and method of making same |
| US5190931A (en) | 1983-10-20 | 1993-03-02 | The Research Foundation Of State University Of New York | Regulation of gene expression by employing translational inhibition of MRNA utilizing interfering complementary MRNA |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4800159A (en) | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
| US5168053A (en) | 1989-03-24 | 1992-12-01 | Yale University | Cleavage of targeted RNA by RNAase P |
| US5459039A (en) | 1989-05-12 | 1995-10-17 | Duke University | Methods for mapping genetic mutations |
| US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| US5424186A (en) | 1989-06-07 | 1995-06-13 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis |
| US5288644A (en) | 1990-04-04 | 1994-02-22 | The Rockefeller University | Instrument and method for the sequencing of genome |
| DE69132531T2 (de) | 1990-12-06 | 2001-09-13 | Affymetrix, Inc. (N.D.Ges.D.Staates Delaware) | Verbindungen und ihre Verwendung in einer binären Synthesestrategie |
| US5384261A (en) | 1991-11-22 | 1995-01-24 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis using mechanically directed flow paths |
| AU8126694A (en) | 1993-10-26 | 1995-05-22 | Affymax Technologies N.V. | Arrays of nucleic acid probes on biological chips |
| US6159693A (en) | 1998-03-13 | 2000-12-12 | Promega Corporation | Nucleic acid detection |
| US6270974B1 (en) | 1998-03-13 | 2001-08-07 | Promega Corporation | Exogenous nucleic acid detection |
| EP2280085A3 (fr) * | 2004-11-01 | 2011-02-23 | George Mason University | Compositions et méthodes pour le diagnostic de troubles du colon |
| WO2010094734A2 (fr) * | 2009-02-19 | 2010-08-26 | Biofocus Dpi B.V. | Procédés d'identification de composés utiles pour le diagnostic et le traitement de maladies liées à une inflammation |
| SI2470671T1 (sl) * | 2009-08-28 | 2015-04-30 | Regeneron Pharmaceuticals, Inc. | Antikinska protitelesa, ki se veĺ˝ejo na veäś kemokinov cc |
-
2012
- 2012-04-16 WO PCT/US2012/033753 patent/WO2013036290A1/fr not_active Ceased
- 2012-04-16 EP EP12829361.0A patent/EP2763540A4/fr not_active Withdrawn
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004045525A2 (fr) * | 2002-11-15 | 2004-06-03 | Morehouse School Of Medicine | Anticorps anti-chimiokines et anticorps anti-recepteurs associes et utilisations de ces anticorps pour inhiber des inflammations |
| WO2005016226A2 (fr) * | 2003-08-14 | 2005-02-24 | Hadasit Medical Research Services & Development Ltd. | Compositions pharmaceutiques comprenant des antagonistes de ccr5 |
| WO2011043654A1 (fr) * | 2009-10-05 | 2011-04-14 | Aak Patent B.V. | Procédé de diagnostic du syndrome du côlon irritable |
| WO2011082218A1 (fr) * | 2009-12-31 | 2011-07-07 | Ira Milton Trachtman | Compositions et procédés pour traitement et prophylaxie d'une maladie intestinale inflammatoire |
Non-Patent Citations (5)
| Title |
|---|
| DELPHINE M SAULNIER ET AL: "Gastrointestinal Microbiome Signatures of Pediatric Patients With Irritable Bowel Syndrome", GASTROENTEROLOGY, ELSEVIER, PHILADELPHIA, PA, vol. 141, no. 5, 24 June 2011 (2011-06-24), pages 1782 - 1791, XP028325678, ISSN: 0016-5085, [retrieved on 20110708], DOI: 10.1053/J.GASTRO.2011.06.072 * |
| ERAN ELINAV ET AL: "NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis", CELL, CELL PRESS, US, vol. 145, no. 5, 22 April 2011 (2011-04-22), pages 745 - 757, XP028221175, ISSN: 0092-8674, [retrieved on 20110502], DOI: 10.1016/J.CELL.2011.04.022 * |
| See also references of WO2013036290A1 * |
| YANFEI CHEN ET AL: "Characterization of fecal microbial communities in patients with liver cirrhosis", HEPATOLOGY, vol. 54, no. 2, 26 June 2011 (2011-06-26), pages 562 - 572, XP055159513, ISSN: 0270-9139, DOI: 10.1002/hep.24423 * |
| YOUNES J. ERRAHALI ET AL: "CCL26-Targeted siRNA Treatment of Alveolar Type II Cells Decreases Expression of CCR3-Binding Chemokines and Reduces Eosinophil Migration: Implications in Asthma Therapy", JOURNAL OF INTERFERON & CYTOKINE RESEARCH, vol. 29, no. 4, 1 April 2009 (2009-04-01), pages 227 - 239, XP055175655, ISSN: 1079-9907, DOI: 10.1089/jir.2008.0051 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2763540A1 (fr) | 2014-08-13 |
| WO2013036290A1 (fr) | 2013-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2763540A4 (fr) | Compositions et procédés d'évaluation et de traitement de maladies et de troubles inflammatoires | |
| EP3494961C0 (fr) | Compositions et procédés pour le traitement de l'inflammation chronique et de maladies inflammatoires | |
| FR23C1022I2 (fr) | Inhibiteurs du recyclage de l'acide biliaire pour traitement de maladies cholestatiques hepatiques pediatriques | |
| EP2877184A4 (fr) | Compositions et traitement pour maladies et troubles oculaires | |
| EP2440559A4 (fr) | Inhibiteurs d'egfr et procédés de traitement de troubles | |
| IL257581A (en) | New dihydropyrimidineisoquinolinones and their pharmaceutical preparations for the treatment of inflammatory disorders | |
| EP2709672A4 (fr) | Compositions et méthodes pour le traitement de maladies de la rétine | |
| EP2875359A4 (fr) | Compositions et procédés de traitement ou de prévention de troubles du syndrome métabolique | |
| EP2800581A4 (fr) | Procédés de traitement des symptômes comportementaux de troubles neurologiques et mentaux | |
| EP2844636A4 (fr) | Procédés pour le traitement de la rétinopathie diabétique et d'autres maladies ophtalmiques | |
| EP2900835A4 (fr) | Procédés et compositions de dépistage et de traitement de troubles du développement | |
| EP2691529A4 (fr) | Procédés et compositions pour traiter des maladies cérébrales | |
| EP2382228A4 (fr) | Compositions et procédés de traitement de maladies inflammatoires et auto-immunes | |
| EP2685987A4 (fr) | Compositions et procédés utiles pour améliorer des maladies liées à l'âge | |
| EP2429530A4 (fr) | Procédés et compositions de traitement de troubles dégénératifs et ischémiques | |
| EP2723347A4 (fr) | Prévention et traitement d'états inflammatoires | |
| EP2773342A4 (fr) | Compositions utiles pour le traitement de maladies virales | |
| EP2717903A4 (fr) | Procédés de traitement pour des maladies rétiniennes | |
| EP2741771A4 (fr) | Méthodes et compositions pour le traitement de maladies auto-immunes et inflammatoires | |
| EP2701694A4 (fr) | Procédés de traitement d'hémoglobinopathies | |
| EP2911660A4 (fr) | Compositions et procédés de traitement de troubles médicaux associés aux strogènes | |
| EP2750606A4 (fr) | Méthodes de diagnostic et de traitement de maladies et d'affections neurologiques et neurodégénératives et procédés associés | |
| EP2720695A4 (fr) | Agents et méthodes de traitement de maladies ischémiques et d'autres maladies | |
| EP2856172A4 (fr) | Compositions et procédés pour l'analyse de la réactivité des plaquettes et de la sélection de traitement | |
| EP2814474A4 (fr) | Procédés de traitement et de prévention de maladies et de troubles du système nerveux central |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20140409 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| AX | Request for extension of the european patent |
Extension state: BA ME |
|
| RA4 | Supplementary search report drawn up and despatched (corrected) |
Effective date: 20150319 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A01N 63/00 20060101AFI20150313BHEP |
|
| 17Q | First examination report despatched |
Effective date: 20160420 |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| INTG | Intention to grant announced |
Effective date: 20170315 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20170726 |